GENEration Hope
Rett SyndromeGene TherapyFoundations

Inside the Fight to Cure Rett Syndrome – Monica Coenraads Interview

Monica Coenraads

Founder and CEO, Rett Syndrome Research Trust

About this conversation

Monica Coenraads, founder and CEO of the Rett Syndrome Research Trust (RSRT), has led the charge to cure Rett Syndrome—raising over $123 million and driving multiple gene therapy programs now in clinical trials. In this in-depth conversation, Monica shares her personal journey from her daughter Chelsea’s diagnosis to building one of the world’s most impactful rare disease research organizations. She explains the evolution of Rett research—from the discovery of MECP2 to today’s cutting-edge genetic medicines including gene therapy, base and prime editing, and RNA trans-splicing.

We discuss: • The founding of RSRT and early breakthroughs • The reversibility discovery that changed everything • The Taysha and Neurogene gene therapy trials • The future of Rett research (Roadmap to Cures 2.0) • How parents can catalyze scientific progress • The power of early diagnosis and newborn screening Stay tuned after the interview for updates on the latest Rett, STXBP1, and Phelan-McDermid Syndrome gene therapy trials. 👉 Subscribe for more interviews with scientists, researchers, and advocates advancing gene therapy for rare genetic disorders. 🌐 Visit GENErationHope.co for global updates and resources.

Key topics

  • Rett research
  • MECP2
  • gene therapy trials
  • foundation strategy

Transcript

Download the full transcript as a text file for accessibility, quoting, and reference.

Download transcript

Related explainers and articles

Related interviews